Publication & Citation Trends
Most Cited Works
Publications
34 total
Detection and Management of Intraocular Inflammation after Brolucizumab Treatment for Neovascular Age-Related Macular Degeneration PDF
Cited by 42
OpenAlex
Incidence and Prevalence of Neovascular Age-Related Macular Degeneration in France between 2008 and 2018 PDF
Cited by 27
OpenAlex
Epidemiology of Treated Diabetes Ocular Complications in France 2008–2018—The LANDSCAPE French Nationwide Study PDF
Cited by 8
OpenAlex
ETOILE: Real-World Evidence of 24 Months of Ranibizumab 0.5 mg in Patients with Visual Impairment Due to Diabetic Macular Edema PDF
Cited by 7
OpenAlex
Real-World Outcomes with Ranibizumab 0.5 mg in Patients with Visual Impairment due to Diabetic Macular Edema: 12-Month Results from the 36-Month BOREAL-DME Study
Cited by 24
OpenAlex
Ranibizumab for choroidal neovascularization secondary to pseudoxanthoma elasticum: 4-year results from the PIXEL study in France PDF
Cited by 28
OpenAlex
Traitement par ranibizumab des néovascularisations choroïdiennes secondaires à un pseudoxanthome élastique : résultats de l’étude observationnelle française PiXEL
Cited by 8
OpenAlex
Research Topics
Retinal Diseases and Treatments
(14)
Retinal Imaging and Analysis
(9)
Cell Adhesion Molecules Research
(5)
Retinal and Optic Conditions
(5)
Glaucoma and retinal disorders
(4)
Frequent Co-Authors
Affiliations
Inserm
Novartis (France)
Novartis (Netherlands)
Centre Hospitalier Universitaire d'Angers
Centre de Médecine Préventive